Search research articles
Contact Us
Filters
Showing results (121-130 of 149) with videos related to
Page
of 15
Sort By:
Obstetrics and Gynecology
|
December 8, 2017
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
Navdeep Pal, Russell R Broaddus, Diana L Urbauer, et al.
Gynecologic Oncology
|
April 11, 2021
Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer
Nicole D Fleming, Shannon N Westin, J Alejandro Rauh-Hain, et al.
Brachytherapy
|
November 1, 2023
Comparing long-term sexual dysfunction across different uterine cancer treatment modalities
Alison K Yoder, David S Lakomy, Juliana Wu, et al.
American Journal of Obstetrics and Gynecology
|
August 25, 2020
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort
Joseph A Dottino, Qian Zhang, David S Loose, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
August 26, 2022
Update on MRI in Evaluation and Treatment of Endometrial Cancer
Ekta Maheshwari, Stephanie Nougaret, Erica B Stein, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 15, 2019
Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists
Jvan Casarin, Francesco Multinu, Nadeem Abu-Rustum, et al.
Gynecologic Oncology
|
February 23, 2025
Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression
Amma Asare, Rebecca Ann Previs, Daniel Spinosa, et al.
American Journal of Obstetrics and Gynecology
|
February 18, 2011
Prospective evaluation of insulin resistance among endometrial cancer patients
Jennifer K Burzawa, Kathleen M Schmeler, Pamela T Soliman, et al.
Cancers
|
February 9, 2021
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. <i>Cancers</i> 2020, <i>12</i>, 2436
Wen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.
Gynecologic Oncology
|
January 18, 2018
Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers
Jennifer Bergstrom, Alessia Aloisi, Shannon Armbruster, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 149) with videos related to
Sort By:
Page
of 15
Obstetrics and Gynecology
|
December 8, 2017
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
Navdeep Pal, Russell R Broaddus, Diana L Urbauer, et al.
Gynecologic Oncology
|
April 11, 2021
Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer
Nicole D Fleming, Shannon N Westin, J Alejandro Rauh-Hain, et al.
Brachytherapy
|
November 1, 2023
Comparing long-term sexual dysfunction across different uterine cancer treatment modalities
Alison K Yoder, David S Lakomy, Juliana Wu, et al.
American Journal of Obstetrics and Gynecology
|
August 25, 2020
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort
Joseph A Dottino, Qian Zhang, David S Loose, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
August 26, 2022
Update on MRI in Evaluation and Treatment of Endometrial Cancer
Ekta Maheshwari, Stephanie Nougaret, Erica B Stein, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 15, 2019
Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists
Jvan Casarin, Francesco Multinu, Nadeem Abu-Rustum, et al.
Gynecologic Oncology
|
February 23, 2025
Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression
Amma Asare, Rebecca Ann Previs, Daniel Spinosa, et al.
American Journal of Obstetrics and Gynecology
|
February 18, 2011
Prospective evaluation of insulin resistance among endometrial cancer patients
Jennifer K Burzawa, Kathleen M Schmeler, Pamela T Soliman, et al.
Cancers
|
February 9, 2021
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. <i>Cancers</i> 2020, <i>12</i>, 2436
Wen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.
Gynecologic Oncology
|
January 18, 2018
Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers
Jennifer Bergstrom, Alessia Aloisi, Shannon Armbruster, et al.
Page
of 15